A. Vimont

Factors predicting statin initiation during childhood in familial hypercholesterolemia: importance of genetic diagnosis.

J. Ferrières, E. Bruckert, F. Boccara, 2022, The Journal of pediatrics.

Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia

M. Krempf, V. Rigalleau, J. Ferrières, 2022, Atherosclerosis plus.

Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry

M. Blachier, M. Massetti, M. Timsit, 2022, Targeted Oncology.

The Ambulatory Medical Assistance (AMA) programme during active‐phase treatment in patients with haematological malignancies: A cost‐effectiveness analysis

J. Blay, M. Blachier, O. Mir, 2022, European journal of cancer care.

Dalbavancin in Real Life: Economic Impact of Prescription Timing in French Hospitals

M. Blachier, G. Béraud, A. Vimont, 2021, Infectious Diseases and Therapy.

Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study

H. Leleu, G. Woimant, P. Richard, 2022, Vox Sanguinis.

Prognostic models for short-term annual risk of severe complications and mortality in patients living with type 2 diabetes using a national medical claim database

H. Leleu, I. Durand-zaleski, S. Béliard, 2023, Diabetology & Metabolic Syndrome.